Renalytix Plc (RNLXY)
4.00
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Renalytix Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 54.60% |
| September 30, 2024 | 19.16% |
| June 30, 2024 | 6.14% |
| March 31, 2024 | -12.34% |
| December 31, 2023 | 32.30% |
| September 30, 2023 | -9.37% |
| June 30, 2023 | -29.92% |
| Date | Value |
|---|---|
| March 31, 2023 | 16.71% |
| December 31, 2022 | 40.35% |
| September 30, 2022 | 28.17% |
| June 30, 2022 | 0.48% |
| March 31, 2022 | 3.33% |
| December 31, 2021 | 29.11% |
| September 30, 2021 | 52.90% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| CompuMed, Inc. | 49.53% |
| Quest Diagnostics, Inc. | 32.53% |
| Labcorp Holdings, Inc. | 27.71% |
| Myriad Genetics, Inc. | 62.51% |
| OPKO Health, Inc. | 37.32% |